Carotid Screening Data To Be Unveiled In February, Following AAA Bill
This article was originally published in The Gray Sheet
Executive Summary
Carotid artery disease screening cost-effectiveness data are being generated by a coalition of vascular surgeons and manufacturers to support the case for a Medicare screening benefit